These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 3678739

  • 21. High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection.
    Bozkaya H, Ayola B, Lok AS.
    Hepatology; 1996 Jul; 24(1):32-7. PubMed ID: 8707278
    [Abstract] [Full Text] [Related]

  • 22. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B.
    Scullard GH, Smith CI, Merigan TC, Robinson WS, Gregory PB.
    Gastroenterology; 1981 Dec; 81(6):987-91. PubMed ID: 7286593
    [Abstract] [Full Text] [Related]

  • 23. Changes in serum hepatitis B virus (HBV) DNA positivity in chronic HBV infection: results of a long-term follow-up study of 138 patients.
    Alberti A, Pontisso P, Fattovich G, Schiavon E, Chemello L, Bortolotti F, Tremolada F, Realdi G.
    J Infect Dis; 1986 Oct; 154(4):562-9. PubMed ID: 3745970
    [Abstract] [Full Text] [Related]

  • 24. Discordance of hepatitis B e antigen/antibody and hepatitis B virus deoxyribonucleic acid in serum. Analysis of 1063 specimens.
    Matsuyama Y, Omata M, Yokosuka O, Imazeki F, Ito Y, Okuda K.
    Gastroenterology; 1985 Nov; 89(5):1104-8. PubMed ID: 4043668
    [Abstract] [Full Text] [Related]

  • 25. Hepatic histologic and immunohistochemical changes in chronic hepatitis B after prolonged clearance of hepatitis B e antigen and hepatitis B surface antigen.
    Perrillo RP, Brunt EM.
    Ann Intern Med; 1991 Jul 15; 115(2):113-5. PubMed ID: 2058858
    [No Abstract] [Full Text] [Related]

  • 26. Beta- and gamma-interferon in chronic active hepatitis B. A pilot trial of short-term combination therapy.
    Caselmann WH, Eisenburg J, Hofschneider PH, Koshy R.
    Gastroenterology; 1989 Feb 15; 96(2 Pt 1):449-55. PubMed ID: 2492011
    [Abstract] [Full Text] [Related]

  • 27. Correlation Between Quantitative Hepatitis B Surface Antigen and Hepatitis B Virus Deoxyribonucleic Acid Levels in Hepatitis B e Antigen-Positive and Hepatitis B e AntigenNegative Chronic Hepatitis B Patients.
    Nirmala VFI, Aryati A, Susianti H, Mustika S.
    Turk J Gastroenterol; 2023 Apr 15; 34(4):378-382. PubMed ID: 37089049
    [Abstract] [Full Text] [Related]

  • 28. High frequency of recurrent viremia after hepatitis B e antigen seroconversion and consolidation therapy.
    Chaung KT, Ha NB, Trinh HN, Garcia RT, Nguyen HA, Nguyen KK, Garcia G, Ahmed A, Keeffe EB, Nguyen MH.
    J Clin Gastroenterol; 2012 Apr 15; 46(10):865-70. PubMed ID: 22941429
    [Abstract] [Full Text] [Related]

  • 29. Comparison of envelope and precore/core variants of hepatitis B virus (HBV) during chronic HBV infection.
    Takayanagi M, Kakumu S, Ishikawa T, Higashi Y, Yoshioka K, Wakita T.
    Virology; 1993 Sep 15; 196(1):138-45. PubMed ID: 8356791
    [Abstract] [Full Text] [Related]

  • 30. Recombinant interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B.
    Barbera C, Bortolotti F, Crivellaro C, Coscia A, Zancan L, Cadrobbi P, Nebbia G, Pillan MN, Lepore L, Parrella T.
    Hepatology; 1994 Aug 15; 20(2):287-90. PubMed ID: 8045488
    [Abstract] [Full Text] [Related]

  • 31. Long-term remission of chronic hepatitis B after alpha-interferon therapy.
    Korenman J, Baker B, Waggoner J, Everhart JE, Di Bisceglie AM, Hoofnagle JH.
    Ann Intern Med; 1991 Apr 15; 114(8):629-34. PubMed ID: 2003708
    [Abstract] [Full Text] [Related]

  • 32. Short-term corticosteroid therapy for chronic active hepatitis B.
    Laskus T, Cianciara J, Loch T, Slusarczyk J.
    Digestion; 1990 Apr 15; 47(2):115-20. PubMed ID: 2292353
    [Abstract] [Full Text] [Related]

  • 33. Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated cryptogenic chronic active hepatitis.
    Czaja AJ, Taswell HF, Rakela J, Schimek CM.
    Mayo Clin Proc; 1990 Oct 15; 65(10):1303-13. PubMed ID: 2170781
    [Abstract] [Full Text] [Related]

  • 34. Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection.
    Lok AS, Lai CL, Wu PC, Leung EK, Lam TS.
    Gastroenterology; 1987 Jun 15; 92(6):1839-43. PubMed ID: 3569757
    [Abstract] [Full Text] [Related]

  • 35. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group.
    Perrillo RP, Schiff ER, Davis GL, Bodenheimer HC, Lindsay K, Payne J, Dienstag JL, O'Brien C, Tamburro C, Jacobson IM, Sampliner R, Feit D, Lefkowitch J, Kuhns M, Meschievitz C, Sanghvi B, Albrecht J, Gibas A, Hepatitis Interventional Therapy Group.
    N Engl J Med; 1990 Aug 02; 323(5):295-301. PubMed ID: 2195346
    [Abstract] [Full Text] [Related]

  • 36. Prospective evaluation of seropositive occult hepatitis B viral infection in lymphoma patients receiving chemotherapy.
    Cheung WI, Lin SY, Leung VK, Fung KS, Lam YK, Lo FH, Chau TN.
    Hong Kong Med J; 2011 Oct 02; 17(5):376-80. PubMed ID: 21979474
    [Abstract] [Full Text] [Related]

  • 37. Virus-associated receptors for polymerized human serum albumin (RpHSA) in patients with chronic active hepatitis B treated with recombinant leukocyte A interferon.
    Gerken G, Manns M, Hess G, Meyer zum Büschenfelde KH.
    Digestion; 1987 Oct 02; 37(2):96-102. PubMed ID: 3040500
    [Abstract] [Full Text] [Related]

  • 38. Hepatitis B virus e antigen-negative chronic infection. Treatment based on glutamic pyruvic transaminase and hepatitis B virus deoxyribonucleic acid cut-off values.
    Guardiola-Arévalo A, Gómez Rodríguez R, Romero Gutiérrez M, Gómez Moreno AZ, García Vela A, Sánchez Simón R, Gómez Hernando C, Andrés Esteban EM.
    Gastroenterol Hepatol; 2018 Mar 02; 41(3):153-162. PubMed ID: 29279233
    [Abstract] [Full Text] [Related]

  • 39. Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers.
    Kao JH, Chen PJ, Lai MY, Chen DS.
    J Med Virol; 2004 Mar 02; 72(3):363-9. PubMed ID: 14748059
    [Abstract] [Full Text] [Related]

  • 40. Long-term follow-up of chronic hepatitis B patients treated with interferon alfa.
    Lok AS, Chung HT, Liu VW, Ma OC.
    Gastroenterology; 1993 Dec 02; 105(6):1833-8. PubMed ID: 8253359
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.